How big is the Global Parkinson's Disease Drugs Market?

The Global Parkinson's Disease Drugs Market size is expected to reach USD 5.56 billion in 2024 and grow at a CAGR of 3.58% to reach USD 6.63 billion by 2029. Read More

What is the current Global Parkinson's Disease Drugs Market size?

In 2024, the Global Parkinson's Disease Drugs Market size is expected to reach USD 5.56 billion. Read More

Who are the key players in Global Parkinson's Disease Drugs Market?

GlaxoSmithKline PLC, Boehringer Ingelheim International GmbH, Newron Pharmaceuticals SPA, F. Hoffmann-La Roche Ltd and AbbVie Inc. are the major companies operating in the Global Parkinson's Disease Drugs Market. Read More

Which is the fastest growing region in Global Parkinson's Disease Drugs Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Parkinson's Disease Drugs Market?

In 2024, the North America accounts for the largest market share in Global Parkinson's Disease Drugs Market. Read More

What years does this Global Parkinson's Disease Drugs Market cover, and what was the market size in 2023?

In 2023, the Global Parkinson's Disease Drugs Market size was estimated at USD 5.37 billion. The report covers the Global Parkinson's Disease Drugs Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Parkinson's Disease Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global Parkinson's Disease DrugsCompanies

This report lists the top Global Parkinson's Disease Drugs companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Global Parkinson's Disease Drugs industry.